chevron_left
De-risking Clinical Trials: Leveraging Toxicology Data During Study Design
Avoid costly late-stage safety surprises.
Learn how toxicology intelligence can help you anticipate, monitor, and manage safety risks — before they derail your study.
Download the eBook to discover how to:
- Use toxicology data to inform safer trial designs
- Identify high-risk patient populations before dosing begins
- Select biomarkers and endpoints that improve trial outcomes
- Understand how combination therapies may amplify toxicity
What is inside?
This 15-page eBook walks you through real-world examples of how integrating toxicology intelligence can:
- Strengthen study protocols and dose selection
- Support regulatory confidence and investor assurance
- Enable proactive risk mitigation throughout development
Includes visual examples of:
- Side-by-side comparisons of patient groups at higher risk for adverse events
- Safety heatmaps for drug combinations
- Translational safety review frameworks
Why read it?
Late-stage safety findings can cause delays, amendments, and lost confidence. This eBook shows you how to apply preclinical and clinical, class-based safety insights to design trials that are safer, faster, and more successful.
This eBook was produced by Clarivate experts behind OFF-X – the translational safety intelligence platform trusted by the FDA and top pharma teams worldwide.
